The safety and efficacy of CAR-T cells in the treatment of prostate cancer: review-Reference-Cited by-同舟云学术

The safety and efficacy of CAR-T cells in the treatment of prostate cancer: review

Published:2021-12-20 Issue:1 Volume:27 Page:22-34
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Saleh Othman Mohammad¹^ORCID,Albakri Khaled Anwer¹^ORCID,Alabdallat Yasmeen Jamal¹^ORCID,Dajani Majd Hamdi¹^ORCID,El Gazzar Walaa Bayoumie²³^ORCID

Affiliation:

1. Medical Student, Faculty of Medicine, Hashemite University, Zarqa, Jordan

2. Department of Basic medical sciences, Faculty of Medicine, Hashemite University, Zarqa, Jordan

3. Department of Medical Biochemistry and molecular biology, Faculty of Medicine, Benha University, Benha city, Egypt

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2021.2016973

Reference193 articles.

1. Abate-Daga , et al. 2019. PSCA: Targeting gamma delta CAR-T Cells for the treatment of bone metastatic castrate-resistant prostate cancer. PCT Patent Application Filed. https://moffitt.org/research-science/innovation/office-of-innovation/available-technologies/immunotherapies/18ma037-psca-targeting-gamma-delta-car-t-cells-for-the-treatment-of-bone-metastatic-castrate-resistant-prostate-cancer/

2. Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

3. Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

4. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression;Cancer Research Communications;2023-08-01